HIV Dynamics

We work closely with the Rakai Health Sciences Program and other collaborators to study HIV transmission in sub-Saharan Africa

We work on a variety of epidemiological studies focused on HIV transmission dynamics and the impact of prevention interventions. Our research largely takes place in Sub-Saharan Africa but we have also collaborated on domestic initatives.

We closely collaborate with the Rakai Health Sciences Program (RHSP) in Uganda, which is one of the leading HIV research institutions in Sub-Saharan Africa. Rakai, located in Southwest Uganda, is where the first AIDS cases were identified in Eastern Africa and today it remains one of the highest-burden districts in the region with an overall HIV prevalence of ~14%. However, within Rakai there is substantial geographic heterogeneity in HIV prevalence ranging from 9-43% at the community-level. We currently support NIH and BMGF initiatives to understand the role of extremely-high-prevalence communities (i.e. "geographic hotspots") and other key populations within the broader regional epidemic with the overarching goal of informing targeting HIV prevention initiatives under PEPFAR Phase III. Our work with RHSP includes dynamic HIV modelling and viral phylogenetics conducted in collaboration with the PANGEA-HIV consortium and researchers (and friends!) at Oxford University and Imperial College London in the UK.

We also have an iniative supported by the Johns Hopkins Center for AIDS Research/NIH to use network models and viral phylogenetics to inform real-time interventions to prevent HIV among young men who have sex with men in Baltimore City, Maryland.

Updates #HIV

2 years 8 months ago

Congratulations to @KateGrabowski and the Rakai team on there important paper on #HIV incidence declines in Rakai in @NEJM
3 years 3 months ago

Congratulations to @katierisher on her exceptional defense of her dissertation today. #HIV
3 years 8 months ago

What can phylogenetics tell us about #HIV transmission? @KateGrabowski and @JustinLessler comment in @TheLancetHIV. https://t.co/b2Pc28yFHG
3 years 8 months ago

RT @KateGrabowski: Congrats to Jess Prodger & Rakai team on new paper looking at inflammation and HIV risk in men! @JHIDDynamics #HIV https://t.co/PFeVseXVtK
4 years 4 weeks ago

Congrats to @KateGrabowski and the whole RHSP team on the their paper in Lancet HIV. With a commentary no less! https://t.co/cDgxIDYvA7 #HIV
4 years 1 month ago

Congrats to @KateGrabowski, Allison A., Errol F., others on @HopkinsCFAR award to study HIV transmission in Baltimore w/phylogenetics! #HIV

Publications

29 Mar 2019

The benefit of immediate compared to deferred ART on CD4+ Cell count recovery in early HIV infection

Sharma S, Schlusser KE, Torre P, Tambussi G, Draenert R, Pinto AN, Metcalf JA, Neaton JD, Laeyendecker O; INSIGHT START Study Group.

AIDS, 2019: 10.1097/QAD.0000000000002219

29 Mar 2019

Inferring HIV-1 transmission networks and sources of epidemic spread in Africa with deep-sequence phylogenetic analysis

Ratmann O, Grabowski MK, Hall M, Golubchik T, Wymant C, Abeler-Dörner L, Bonsall D, Hoppe A, Brown AL, de Oliveira T, Gall A, Kellam P, Pillay D, Kagaayi J, Kigozi G, Quinn TC, Wawer MJ, Laeyendecker O, Serwadda D, Gray RH, Fraser C; PANGEA Consortium and Rakai Health Sciences Program.

Nat Commun, 2019: 10(1): 1411, 10.1038/s41467-019-09139-4

12 Feb 2019

Cross-sectional HIV Incidence Estimation Accounting for Heterogeneity Across Communities

Xu Y, Laeyendecker O, Wang R

Biometrics, 2019: 10.1111/biom.13046

24 Apr 2019

Operational characteristics of antiretroviral therapy clinics in Zambia: a time and motion analysis

Tampi RP, Tembo T, Mukumba-Mwenechanya M, Sharma A, Dowdy DW, Holmes CB, Bolton-Moore C, Sikazwe I, Tucker A, Sohn H

BMC Health Serv Res, 2019: 19(1): 244, 10.1186/s12913-019-4096-z

4 Oct 2019

Longitudinal antibody responses in people who inject drugs infected with similar HIV strains

Redd AD, Doria-Rose NA, Weiner JA, Nason M, Seivers M, Schmidt SD, Laeyendecker O, Martens C, Bruno D, Keele BF, Raju N, Georgiev IS, Lamers SL, Astemborski J, Kirk GD, Mascola JR, Ackerman ME, Mehta SH, Quinn TC

J Infect Dis, 2019: 10.1093/infdis/jiz503

30 Aug 2019

Cross-sectional HIV incidence estimation in an evolving epidemic

Morrison D, Laeyendecker O, Brookmeyer R

Stat Med, 2019: 38(19): 3614-3627, 10.1002/sim.8196

30 Apr 2019

Comprehensive Profiling of HIV Antibody Evolution

Eshleman SH, Laeyendecker O, Kammers K, Chen A, Sivay MV, Kottapalli S, Sie BM, Yuan T, Monaco DR, Mohan D, Wansley D, Kula T, Morrison C, Elledge SJ, Brookmeyer R, Ruczinski I, Larman HB

Cell Rep, 2019: 27(5): 1422-1433, 10.1016/j.celrep.2019.03.097

7 Nov 2019

Advancing HIV Vaccine Research With Low-Cost High-Performance Computing Infrastructure: An Alternative Approach for Resource-Limited Settings

Mabvakure BM, Rott R, Dobrowsky L, Van Heusden P, Morris L, Scheepers C, Moore PL

Bioinform Biol Insights, 2019: 13: 10.1177/1177932219882347

Infectious Disease Dynamics

HIV Dynamics

HIV Dynamics

Updates #HIV

Publications

Pages

Search form

HIV Dynamics

HIV Dynamics

Updates #HIV

Publications

Pages